Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 17, 2022
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
[ Thu, Feb 17th 2022
] - WOPRAI
Andrew Berens Downgraded (BPMC) to Hold and Decreased Target to $82 on, Feb 17th, 2022
Andrew Berens of SVB Leerink, Downgraded "Blueprint Medicines Corporation" (BPMC) to Hold and Decreased Target from $93 to $82 on, Feb 17th, 2022.
Andrew has made no other calls on BPMC in the last 4 months.
There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $92 on, Tuesday, February 1st, 2022
These are the ratings of the 3 analyists that currently disagree with Andrew
- Bradley Canino of "Stifel" Upgraded from Hold to Strong Buy and Decreased Target to $95 on, Tuesday, January 25th, 2022
- Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $122 on, Monday, January 3rd, 2022
- Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $133 on, Wednesday, November 10th, 2021
